BRENDA (BRaunschweig ENzyme DAtabase), founded in 1987 by Dietmar Schomburg, is a comprehensive protein function database, containing enzymatic and metabolic information extracted from the primary literature. Presently, the database holds data on more than 40 000 enzymes and 4460 different organisms, and includes information about enzyme-ligand relationships with numerous chemical compounds. The collection of molecular and biochemical information in BRENDA provides a fundamental resource for research in biotechnology, pharmacology, medicinal diagnostics, enzyme mechanics, and metabolism. BRENDA is accessible free of charge to the academic community at http://www.brenda.uni-koeln.de/; commercial users need a license available from http://www.science-factory.com/
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0968-0004(01)02027-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Breast Implant Surgery: The Importance of Informed Health Care Decisions and Outcome Monitoring.
Plast Aesthet Nurs (Phila)
December 2024
Jessica Prothe, BSN, RN, is a Graduate Nursing Student at Northern Illinois University, DeKalb, Illinois.
Breast implant surgery is a popular, globally performed, and frequently requested cosmetic and reconstructive surgical procedure. Breast implant surgery can cause implant-associated systemic symptoms and types of implant-associated cancers, so it is vital to monitor patient outcomes. Most patients who undergo breast implant surgery do not experience health problems.
View Article and Find Full Text PDFHow long is prolonged mechanical ventilation in children, and does it matter?
Lancet Child Adolesc Health
January 2025
Department of Paediatrics and Child Health, University of Cape Town, Cape Town 7701, South Africa. Electronic address:
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
Diabetes Ther
December 2024
Bayer AG, Berlin, Germany.
Introduction: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148), we described and compared cohorts of adult patients with CKD and T2D initiating a sodium-glucose cotransporter 2 inhibitor (SGLT2i) before the launch of finerenone in Europe, Japan, and the United States (US).
Methods: This was a multinational, multi-cohort study of patients with T2D in five data sources: the Danish National Health Registers (DNHR) (Denmark), PHARMO Data Network (The Netherlands), Valencia Health System Integrated Database (VID) (Spain), Japan Chronic Kidney Disease Database Extension (J-CKD-DB-Ex) (Japan), and Optum's de-identified Clinformatics Data Mart Database (CDM) (US).
Supporting Teachers and Students: The Role of AI in Shaping the Future of Education.
Cyberpsychol Behav Soc Netw
December 2024
Brenda K. Wiederhold Editor-in-Chief.
Application of a minimally invasive full-thickness autologous microcolumn skin harvesting device for donor site tissue collection and augmenting wound healing in a porcine wound model.
Int Wound J
December 2024
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Using a 6-week porcine full-thickness excisional wound grafting model, we evaluated the Autologous Regeneration of Tissue (ART®) System, a novel skin harvesting device designed to collect autologous full-thickness autologous microcolumns (FTAM) at 0.5 mm in diameter. The donor skin sites were harvested using the ART® System and compared to split-thickness skin grafts (STSGs).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!